is 4.2M / 15.2% - not insignificant......any comments?
If we enjoy a good Q - good Opus sales - good growth - maybe even an acquisition......could see
a short squeeze!! Wouldn't that be something!
bio - as many of us anticipate along with earnings and Opus 60 - CAN'T WAIT FOR ANOTHER
ACQUISITION......AND DETERMINE IF ITS SMALL MED OR LARGE.
Again appears dillution along with the long long term timeline is trumping the possibilities. if there were $30m in the coffers this would have taken off off off!
appears we have unchartered territory of $25.XX resistance that RGEN has been unable to close and
hold......its never easy and sometimes takes 2-3 attempts to break through.....we wait but like the action.
bio - perfectly said.
Respectful but this guy has a very hard head!
Well in any event there are always diverse opinions and dudo simply cannot provide a valid argument.......no biggie.
Lots of BLINDERS ON IN TERMS OF THE COST FOR 2 DRUGS FOR P1 - P2 & P3!!! WE WILL WITNESS MUCH DILLUTION OVER THE NEXT 2-3 YEARS AND THIS WILL NOT MORE THAN A 2 YEAR HOLD!!
The Company started 2015 with $8M cash, sufficient to run a Phase 1 study for Cantrixil. However for the purposes of risk mitigation and maximizing shareholder value, it has been decided to bring Cantrixil, TRXE-
009 and Anisina progressively into the clinic over the next 15 months. For this, shareholder approval will be sought later in 2015 to raise additional funds.
Sorry but your information is totally inaccurate and misinformed / check the 2 acquisitions (refine & novazyme) that have both proved to be extremely successful resulting in great gains in top & bottom line as well as huge infrasture and technical gains.....more of the same to follow this year!!
•Funding strategies: The Company started 2015 with $8M cash, sufficient to run a Phase 1 study for Cantrixil. However for the purposes of risk mitigation and maximizing shareholder value, it has been decided to bring Cantrixil, TRXE-009 and Anisina progressively into the clinic over the next 15 months. For this, shareholder approval will be sought later in 2015 to raise additional funds.
Love this stock but WHY THE HUGE DROP FROM 50 TO 30ISH?? where did you find $250 in cash - yahoo shows much less??
Thanks - these post starting with lets see are compelling!
Appears the substance is moving us up: how we are preparing for growth, management in place, infrastructure in place, decent market for top and bottom line growth, yes there are barriers for entry that preclude small / med companies from entering as competitors inspite of recent post to the contrary, product expansion, strong chart, cash cash, etc hate to be redundant but thats the growth engine and it is moving along very well (yes we could have a hiccup as any company - always unforseen roadblocks and stocks go up and down as a result).
VIV - excellent post - appreciated. Its post like this that make our message board special......unfortunately we recently
have a couple of dumbells choosing to name call and make
"little boy" accusations.
Love substance over hype and rumors......rgen keeps the growth train rolling.......
great mgmt. - great business model - great chart - expanding product line based on customer needs - whats not to love.......and.....
da cash cash cash.......can't wait to see how it is used and the impact on top and bottom line and of course share price.
dudo - with that unwavering confidence sounds like you have taken a strong short position - on all of these message boards shorts are not "loved" to say the least / see no reason for that and believe it lends itself to depth of thought and different perspectives and strategies.......good luck......do you have a large position / day trade or swing trade or ??
Have not been persuaded to change my strong belief that we continue strong / no lower than $19 support.
Yesterday was a strong day with good volume 463,600 shares / important as I thought we could easily slide down the big spike up and go right back down to 19-20 but we had buyers come in on volume so more optimistic that we base out in the 22-24 range but who really knows......also waiting for the Q and really can't wait for an acquisition.......to me its all good and a fairly safe bet but we all realize a disappointing Q could knock any stock down down.
nboy - personally always invite shorts / rather than name calling - why get so bent
out of shape with a different opinion.......actually enjoy viewing other opinions since in
some situations they have quality comments that make sense (in this
case not so much ha!).
Our rgen message board has been really cool and not adversarial.
Not sure yoiiu can use a pe with rgen.....its a growth stock that will acquire and get larger and improve top and bottom line in a growth sector with so many large pharma requiring our various products.......so if u are very confident in what you wrote this is a super super short candidate for you.
Can't imagine we do not slide down to $20 or $19......where we started prior to the spike up.
No biggie - we will come back stronger with a more expanded business model and opportunities.